Etiometry Inc.
BOSTON, MA · CIK 0001719571 · Medtech · Private
Clinical analytics platform that combines multiple physiologic data streams to assess oxygen delivery insufficiency in critically ill pediatric cardiac patients
etiometry.com →- Grants
- $8.0M
- 6 awards
- Sector median: 1
- Raised
- $8.2M
- 3 Form D · Apr 2023
- 42 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 38
- 10 granted · 28 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Risk Assessment Using Noninvasive Measurements in Postoperative Pediatric Patients | $999,566 | |
| Federal grant | Department of Health and Human Services · Phase II · Risk Assessment Using Noninvasive Measurements in Postoperative Pediatric Patients | $997,004 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Risk-based Patient Monitoring for Pediatric Cardiac Patients | $992,238 | |
| Federal grant | Department of Health and Human Services · Phase II · Risk-based Patient Monitoring for Pediatric Cardiac Patients | $2,987,703 | |
| Federal grant | Department of Health and Human Services · Phase II · Risk-based Patient Monitoring for Pediatric Cardiac Patients | $995,757 | |
| Federal grant | Department of Health and Human Services · Phase II · Risk-based Patient Monitoring for Pediatric Cardiac Patients | $999,708 | |
| Private capital raised | Form D · SEC | $2,002,992 | |
| Private capital raised | Form D · SEC | $5,718,400 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1313 | Optain Health, Inc. | — | $31M |
| 1314 | FRESHAIR SENSOR CORPORATION | — | $32M |
| 1315 | NEXTGENJANE INC | — | $19M |
| 1316 | Etiometry Inc. | — | $8.2M |
| 1317 | AGIL THERAPEUTICS, INC. | — | — |
| 1318 | BennuBio Inc | — | $6.8M |
| 1319 | Triangle Biotechnology, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Dimitar BaronovDirector · Executive Officer
- Evan ButlerDirector · Executive Officer
- Shane CookeDirector · Executive Officer
- Guy FishDirector
- Jesse LockDirector · Executive Officer
- Gregory MartinDirector
- Eric MeyersDirector
- Peter RockDirector · Executive Officer
- Brad RosenblumExecutive Officer
- Bradley RosenblumExecutive Officer
- David ShepherdDirector
- Nelson StacksDirector
Patents
- Systems And Methods For Transitioning Patient Care From Signal Based Monitoring To Risk Based Monitoringapplication
- Systems And Methods For Optimizing Medical Care Through Data Monitoring And Feedback Treatmentapplication
- Systems And Methods For Transitioning Patient Care From Signal-based Monitoring To Risk-based Monitoringgranted
- Clinical Education Method And Systemapplication
- Systems And Methods For Medical Care Through Data Monitoring And Feedback Treatmentapplication
- Systems and Methods for Optimizing Medical Care Through Data Monitoring and Feedback Treatmentgranted
- System And Methods For Transitioning Patient Care From Signal Based Monitoring To Risk Based Monitoringgranted
- System And Methods For Transitioning Patient Care From Signal Based Monitoring To Risk Based Monitoringgranted
- System And Method For Generation And Testing Of Clinical Decision Support Protocols To Assist With Targeted Patient Interventionsapplication
- System And Method For Generation And Testing Of Clinical Decision Support Protocols To Assist With Targeted Patient Interventionsapplication
- System and Method for Providing Clinical Decision Supportapplication
- System And Methods For Continuously Assessing Performance Of Predictive Analytics In A Clinical Decision Support Systemapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.